WILMINGTON, Del. – Purdue Pharma LP filed for bankruptcy with a more than $10 billion plan to settle claims that it fueled the U.S. opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller. The Chapter 11 filing on Sunday in White Plains, N.Y., is designed to short-circuit more than 2,000 lawsuits against Purdue…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.